Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1180237.RAz5J-zoE6mjO6_UpGa0fmF_vCVEt9hgO2Aw5E6l1kz7o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1180237.RAz5J-zoE6mjO6_UpGa0fmF_vCVEt9hgO2Aw5E6l1kz7o130_assertion type Assertion NP1180237.RAz5J-zoE6mjO6_UpGa0fmF_vCVEt9hgO2Aw5E6l1kz7o130_head.
- NP1180237.RAz5J-zoE6mjO6_UpGa0fmF_vCVEt9hgO2Aw5E6l1kz7o130_assertion description "[Taken together, our findings indicate that loss of miR-100 promotes the metastatic ability of prostate cancer cells at least partially by upregulating AGO2 expression through modulating migration, invasion, EMT and stemness of cancer cells, and suggest that miR-100/AGO2 may play an important role in regulating the metastasis of prostate cancer and is a potential target of prevention and therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1180237.RAz5J-zoE6mjO6_UpGa0fmF_vCVEt9hgO2Aw5E6l1kz7o130_provenance.
- NP1180237.RAz5J-zoE6mjO6_UpGa0fmF_vCVEt9hgO2Aw5E6l1kz7o130_assertion evidence source_evidence_literature NP1180237.RAz5J-zoE6mjO6_UpGa0fmF_vCVEt9hgO2Aw5E6l1kz7o130_provenance.
- NP1180237.RAz5J-zoE6mjO6_UpGa0fmF_vCVEt9hgO2Aw5E6l1kz7o130_assertion SIO_000772 24805183 NP1180237.RAz5J-zoE6mjO6_UpGa0fmF_vCVEt9hgO2Aw5E6l1kz7o130_provenance.
- NP1180237.RAz5J-zoE6mjO6_UpGa0fmF_vCVEt9hgO2Aw5E6l1kz7o130_assertion wasDerivedFrom befree-2016 NP1180237.RAz5J-zoE6mjO6_UpGa0fmF_vCVEt9hgO2Aw5E6l1kz7o130_provenance.
- NP1180237.RAz5J-zoE6mjO6_UpGa0fmF_vCVEt9hgO2Aw5E6l1kz7o130_assertion wasGeneratedBy ECO_0000203 NP1180237.RAz5J-zoE6mjO6_UpGa0fmF_vCVEt9hgO2Aw5E6l1kz7o130_provenance.